MMP9 and neoplasm: In the MMP-9- and glutathione-rich tumor microenvironment, the MMP-9-mediated degradation of the peptides released chemotherapeutic drugs, enhancing dendritic cell activation, T cell expansion, and inhibiting tumor growth [151].